# Health Guard Biomed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/health-guard-biomed

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.healthguard-biomed.com
- Total disclosed funding: $14M
- Latest round: Series A (Sep 19, 2022)
- Investors on record: 7

## About

Based in Jiangsu, China and founded in 2020, Haisi Gaide (Suzhou) Biomedical Technology Co., Ltd., trading as Health Guard Biomed, operates as a medical device company dedicated to providing implantable medical devices for ophthalmic diseases. It has an R&D centre in Shanghai and a machining centre in Nantong. In September 2026, it closed a venture funding led by Fujian Venture.

The company mainly provides implantable medical devices for ophthalmic diseases. The product pipeline involves implantable medical devices and related supporting diagnostic and treatment equipment for glaucoma, cataracts, and fundus lesions. Its main product is the MicroCOGO® Trabecular Mesh Micro-Stent Drainage System, which is used to treat early-stage open-angle glaucoma. Health Guard Biomed also provides Haisiwei® Rebound Tonometer, which can be used for daily monitoring of intraocular pressure in glaucoma.

The company generates revenue by providing implantable medical devices and related supporting diagnostic and treatment equipment for eye diseases.

The company will use the latest funding to advance the commercialization of core MIGS products and to develop the retinal-based brain-computer interface (BCI) pipeline for visual restoration, as the company continues to pursue a dual-track strategy of commercializing mature products alongside independent innovation in cutting-edge technologies.

## Funding rounds

- Series A, Sep 19, 2022, $14M — Delian Capital, TF Capital, Rongquan Investment Group, BioTrack Capital, Shanghai Azbrook Asset Management
- Angel, Apr 20, 2021 — China Growth Capital, TF Capital, TigerYeah Capital

## Investors

- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Angel
- TF Capital — Angel, Series A
- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel
- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series A
- Rongquan Investment Group — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A
- Shanghai Azbrook Asset Management — Series A